Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPRELAX: Hyoscine Butylbromide During Laparoscopic Transcystic Papillary Balloon Dilation
NCT07814976Recruiting
- Sponsor
- Riga East Clinical University Hospital
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Open-label trial of hyoscine butylbromide in choledocholithiasis (2 arms), sponsored by Riga East Clinical University Hospital. Primary endpoint: Balloon Inflation Pressure Required for Papillary Dilation. Started Jan 2026; status: recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
choledocholithiasis
Beyond the preview
Go deeper on NCT07814976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814976.